共 50 条
- [21] Switching to Insulin Glargine 300 U/mL (Gla-300) after Failure of Advanced Insulin Therapy (IT) with Other Basal Insulins (BI) in Patients (Pts) with Type 2 Diabetes (T2DM) Improved Glycemic Control[J]. DIABETES, 2018, 67Pscherer, StefanFritsche, AndreasAnderten, HelmutPegelow, KatrinSeufert, JochenPfohl, Martin
- [22] Switching to Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control and Reduces Nocturnal Hypoglycemia in Patients (Pts) with Type 2 Diabetes (T2DM) on Basal Insulin Supported Oral Therapy (BOT)[J]. DIABETES, 2018, 67Seufert, JochenFritsche, AndreasAnderten, HelmutPegelow, KatrinPscherer, StefanPfohl, Martin
- [23] Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed-Ratio Combination vs. Insulin Glargine in Japanese Patients with T2DM[J]. DIABETES, 2019, 68Kaneto, HideakiTakami, AkaneSpranger, RobertAmano, AtsushiWatanabe, DaisukeNiemoeller, Elisabeth
- [24] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)[J]. DIABETES, 2001, 50 : A68 - A68Weinzimer, SAMcKnight, WJMurphy, KJawad, AFCelona-Jacobs, NHaque, AKatz, LEL
- [25] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)[J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159Toplak, HVercruysse, FSun, XFitchet, M
- [26] Triple therapy in type 2 diabetes (T2DM): Benefits of insulin glargine (GLAR) over rosiglitazone (RSG) added to combination therapy of sulfonylurea plus metformin (SU plus MET) in insulin-naive patients[J]. DIABETES, 2004, 53 : A145 - A145Rosenstock, JSugimoto, DStrange, PStewart, JSoltes-Rak, EDailey, G
- [27] BUDGET IMPACT ANALYSIS OF INSULIN GLARGINE-300U/ML (GLA-300) FOR TREATMENT OF T1DM AND T2DM IN ALGERIAN SETTING[J]. VALUE IN HEALTH, 2022, 25 (12) : S121 - S121Azzoug, S.Levy, P.Aissaoui, A.Hachelaf, Z.
- [28] Initiating Basal Insulin Supported Oral Therapy (BOT) with Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control in Patients (Pts) with Type 2 Diabetes (T2DM) without Increasing Hypoglycemia Risk[J]. DIABETES, 2018, 67Pfohl, MartinFritsche, AndreasAnderten, HelmutPegelow, KatrinPscherer, StefanSeufert, Jochen
- [29] Local Tolerability of Insulin Degludec is Comparable to Insulin Glargine: A Meta-Analysis of T1DM and T2DM[J]. DIABETES, 2012, 61 : A230 - A230Meneghini, Luigi F.Schumm-Draeger, Petra-MariaHarris, StewartGall, Mari-AnneLassota, NathanChristiansen, Jens S.
- [30] Efficacy of canagliflozin (CANA) in combination with metformin (MET) in patients with T2DM: Results from 3 studies[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S118 - S118Qiu, RongXie, JohnHamilton, GillCanovatchel, WilliamFegade, Mayuresh